trending Market Intelligence /marketintelligence/en/news-insights/trending/u15164U-ky51MnuNaltfeg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

China Grand Pharmaceutical takeover of Sirtex Medical cleared by US committee

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

China Grand Pharmaceutical takeover of Sirtex Medical cleared by US committee

The Committee on Foreign Investment in the U.S. cleared Sirtex Medical Ltd.'s takeover by China Grand Pharmaceutical and Healthcare Holdings Ltd. and CDH Genetech Ltd.

Hong Kong-based China Grand Pharmaceutical said the U.S. committee cleared the transaction after receiving certain assurances from the companies that there were no unresolved national security concerns related to the acquisition.

Sydney-based Sirtex Medical, which develops cancer treatments using novel small particle technology, was acquired by the consortium for A$33.60 per share.

China Grand Pharmaceutical said the acquisition has allowed it to enter the field of liver cancer treatment.